CRIS Current Research Information System

DE PONTI, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.397
AS - Asia 12.412
EU - Europa 9.836
AF - Africa 814
SA - Sud America 711
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 36
Totale 37.243
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.247
SG - Singapore 3.421
VN - Vietnam 3.145
CN - Cina 2.910
IT - Italia 2.410
GB - Regno Unito 2.317
DE - Germania 1.189
HK - Hong Kong 1.124
SE - Svezia 771
IN - India 590
FR - Francia 553
UA - Ucraina 551
BR - Brasile 525
RU - Federazione Russa 497
IE - Irlanda 327
NL - Olanda 291
JP - Giappone 271
CI - Costa d'Avorio 227
TG - Togo 216
KR - Corea 201
FI - Finlandia 192
ZA - Sudafrica 184
EE - Estonia 144
PH - Filippine 102
CA - Canada 90
JO - Giordania 90
TH - Thailandia 86
CH - Svizzera 81
BE - Belgio 78
AR - Argentina 77
HR - Croazia 74
ID - Indonesia 74
BG - Bulgaria 73
AT - Austria 60
PL - Polonia 52
BD - Bangladesh 51
NG - Nigeria 49
SC - Seychelles 48
TW - Taiwan 48
TR - Turchia 43
SA - Arabia Saudita 40
IQ - Iraq 39
ES - Italia 38
MX - Messico 36
GR - Grecia 35
EU - Europa 34
UZ - Uzbekistan 30
AU - Australia 29
EC - Ecuador 29
PK - Pakistan 26
CO - Colombia 22
LT - Lituania 21
CL - Cile 20
CZ - Repubblica Ceca 17
RO - Romania 17
DZ - Algeria 15
EG - Egitto 15
IR - Iran 15
MY - Malesia 15
MA - Marocco 14
IL - Israele 12
KE - Kenya 12
LB - Libano 12
PE - Perù 12
PT - Portogallo 12
TN - Tunisia 11
VE - Venezuela 11
AZ - Azerbaigian 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
KZ - Kazakistan 8
NZ - Nuova Zelanda 8
SK - Slovacchia (Repubblica Slovacca) 7
AL - Albania 6
DK - Danimarca 6
GH - Ghana 6
HU - Ungheria 5
KG - Kirghizistan 5
BA - Bosnia-Erzegovina 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
JM - Giamaica 4
NP - Nepal 4
OM - Oman 4
HN - Honduras 3
KH - Cambogia 3
LK - Sri Lanka 3
MN - Mongolia 3
NI - Nicaragua 3
PS - Palestinian Territory 3
SN - Senegal 3
SV - El Salvador 3
UY - Uruguay 3
AM - Armenia 2
BO - Bolivia 2
BW - Botswana 2
CY - Cipro 2
KW - Kuwait 2
PA - Panama 2
RS - Serbia 2
Totale 37.213
Salva come PNG Salva come JPEG
Città #
Singapore 2.334
Southend 2.005
Fairfield 1.279
Ashburn 1.205
Hong Kong 1.047
Chandler 939
Ho Chi Minh City 669
Dong Ket 656
Wilmington 623
Woodbridge 574
Seattle 561
San Jose 546
Ann Arbor 543
Santa Clara 542
Hanoi 527
Princeton 493
Houston 491
Hefei 453
Cambridge 431
Bologna 422
Beijing 406
Dublin 318
Boardman 305
Jacksonville 278
Los Angeles 256
Abidjan 227
Lauterbourg 220
Lomé 216
Tokyo 213
Westminster 187
Padova 177
Nanjing 173
Seoul 162
Dallas 157
Helsinki 157
Berlin 150
Milan 145
New York 130
Rome 129
Buffalo 120
Redmond 115
Council Bluffs 112
Saint Petersburg 102
Jinan 91
San Diego 90
Amman 88
Turin 83
Haiphong 78
Shanghai 77
Medford 76
Da Nang 75
Shenyang 73
Sofia 72
Bremen 71
Brussels 70
Florence 67
Frankfurt am Main 67
Guangzhou 66
Redondo Beach 63
The Dalles 63
Changsha 62
Nanchang 61
Hebei 60
São Paulo 60
Bern 58
Falls Church 58
Munich 58
Mülheim 58
Verona 51
London 50
Tianjin 48
Zhengzhou 47
Des Moines 44
Jiaxing 44
Orem 44
Bengaluru 43
Dearborn 43
Toronto 43
Bangkok 42
Jakarta 39
Abeokuta 38
Chicago 38
Vienna 34
Yubileyny 33
Shenzhen 32
Hangzhou 31
Mahé 31
Phoenix 31
Wuhan 31
Redwood City 30
Amsterdam 29
Nuremberg 29
Biên Hòa 28
Ningbo 28
Norwalk 27
Olalla 27
Falkenstein 26
Taipei 26
Hải Dương 25
Biella 24
Totale 23.676
Salva come PNG Salva come JPEG
Nome #
Interazioni tra sistema serotoninergico e mediatori dell'infiammazione nella fisiopatologia della sindrome dell'intestino irritabile 754
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe. 487
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems 337
Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators 312
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system 305
Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS) 295
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals 283
Biomarkers of Kidney Injury in Very-low-birth-weight Preterm Infants: Influence of Maternal and Neonatal Factors 281
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage 270
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies 269
Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems 259
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 256
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 255
hERG-related drug toxicity and models for predicting hERG liability and QT prolongation 252
Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons 251
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 245
Diagnosis and therapy of irritable bowel syndrome 240
Farmacologia. Azioni e Reazioni dei farmaci. 240
Elementi di Farmacologia: Compendio per l’esame. 238
Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database. 237
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome 235
Drug-Induced Renal Damage in Preterm Neonates: State of the Art and Methods for Early Detection 234
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 233
Advancements in drug development for diarrhea-predominant irritable bowel syndrome 229
beta3-adrenoceptors in the gut: evidence for a possible role in enteric neuroimmunomodulation 226
Pattern of drug use among preterm neonates: Results from an Italian neonatal intensive care unit 225
Severe quetiapine voluntary overdose successfully treated with a new hemoperfusion sorbent 221
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. 220
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System 219
Risk of hospitalization from drug-drug interactions in the Elderly: real-world evidence in a large administrative database 219
Antibacterial macrolides: a drug class with a complex pharmacological profile 217
Predictors of antipsychotic prescription in a Northern Italian District (Bologna) 215
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. 212
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. 211
Animal models of chemically induced intestinal inflammation: Predictivity and ethical issues 210
Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement 205
Antimicrobials and the Risk of Torsades de Pointes. The Contribution from Data Mining of the US FDA Adverse Event Reporting System 205
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 203
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System 201
Non-peptidyl low molecular weight radical scavenger IAC attenuates DSS-induced colitis in rats. 199
Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis 195
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 195
Altered Serotonin Signaling and Extrinsic Sensory Neuron Activation in Irritable Bowel Syndrome 195
Social and clinical descriptors of antipsychotic prescription 194
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey 193
Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database 192
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System 191
Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003. 189
Posterior Reversible Encephalopathy Syndrome Associated With Licorice Consumption: A Case Report in a 10-Year-Old Boy 188
Adverse events associated with the use of direct-acting oral anticoagulants in clinical practice: beyond bleeding complications 188
Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project. 188
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System 188
The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project 186
Neuroplasticity of the enteric nervous system induced by inflammatory conditions in the gut 185
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 183
Drug-induced Kounis syndrome: A matter of pharmacovigilance 183
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 182
An update on the first decade of the European centralized procedure: how many innovative drugs? 181
Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants 180
Paraneoplastic Syndrome 179
Clinically important drug-drug interactions in poly-treated elderly outpatients: A campaign to improve appropriateness in general practice 179
Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis 179
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People 177
Detection of D-penicillamine in skin lesions in a case of dermal elastosis after a previous long-term treatment for Wilson's disease 177
5-HT7 Receptors Modulate Peristalsis and Accommodation in the Guinea Pig Ileum 176
Drug-induced renal injury in neonates: challenges in clinical practice and perspectives in drug development 176
Effects of the non-peptidyl low molecular weight radical scavenger IAC in DNBS-induced colitis in rats. 176
Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis 176
Aspetti clinici ed anticorpi anti-neurone nella malattia celiaca con disordini neurologici 175
Case Report. 175
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study 174
Protection from DNBS-induced colitis by the tachykinin NK1 receptor antagonist SR140333 in rats 174
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems 174
Pro-arrhythmic potential of oral antihistamines (H1): Combining adverse event reports with drug utilization data across Europe 173
Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing 172
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction 171
Enteric neuroplasticity evoked by inflammation 170
Using artificial intelligence to create diverse and inclusive medical case vignettes for education 169
QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus 169
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics 168
The hERG K+ channel: target and antitarget strategies in drug development. 168
Academic output from EU-funded health research projects 167
Dapagliflozin and cardiovascular outcomes: anything else to DECLARE? 167
A clinical pharmacology and therapeutics teacher's guide to race-based medicine, inclusivity, and diversity 166
Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology 164
Antimicrobial-induced torsades de pointes: towards risk stratification by data mining of the FDA Adverse Event Reporting System. 162
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance 162
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment 161
La condivisione dei trattamenti farmacologici in psichiatria e la percezione degli effetti avversi ai farmaci antipisicotici da medico, paziente e familiare 160
Delayed gastric emptying in functional dyspepsia 159
Excipients in medicinal products used in gastroenterology as a possible cause of side effects. 158
L'essenziale in Farmacologia Clinica 156
Inflammatory neuropathies of the enteric nervous system 156
Recurrence of pericarditis after influenza vaccination: a case report and review of the literature 156
Farmaci lassativi e purganti 155
Fattori determinanti nell'utilizzo dei farmaci antipsicotici 155
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System 155
Use and Perception of Phytoestrogens in Postmenopausal Women: Result of a Questionnaire-Based Survey 154
Pharmacological and Regulatory Aspects of QT Prolongation 152
ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations 152
Totale 20.825
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.330
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.395 0 0 0 0 0 0 0 0 0 180 209 1.006
2021/20224.483 556 147 257 225 361 275 185 276 176 228 1.084 713
2022/20234.512 446 555 300 564 309 314 211 286 764 194 388 181
2023/20241.573 129 218 141 167 151 239 67 116 54 113 105 73
2024/20255.333 296 866 619 296 843 319 349 202 142 316 172 913
2025/202611.647 955 1.093 1.206 844 1.429 761 1.724 405 2.424 806 0 0
Totale 37.989